BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38646499)

  • 1. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).
    Wang Z; Chang Y; Sun H; Li Y; Tang T
    Oncol Lett; 2024 Jun; 27(6):257. PubMed ID: 38646499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links.
    Jurjus A; Eid A; Al Kattar S; Zeenny MN; Gerges-Geagea A; Haydar H; Hilal A; Oueidat D; Matar M; Tawilah J; Hussein IH; Schembri-Wismayer P; Cappello F; Tomasello G; Leone A; Jurjus RA
    BBA Clin; 2016 Jun; 5():16-24. PubMed ID: 27051585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
    Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
    Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation.
    Rivera AP; Flores Monar GV; Islam H; Puttagunta SM; Islam R; Kundu S; Jha SB; Sange I
    Cureus; 2022 Feb; 14(2):e22636. PubMed ID: 35371788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.
    Huang W; Aabed N; Shah YM
    Antioxid Redox Signal; 2023 Sep; 39(7-9):551-568. PubMed ID: 36792928
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
    Yin Y; Wan J; Yu J; Wu K
    Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease and carcinogenesis.
    Nagao-Kitamoto H; Kitamoto S; Kamada N
    Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy.
    Nardone OM; Zammarchi I; Santacroce G; Ghosh S; Iacucci M
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease.
    Shen Q; Huang Z; Yao J; Jin Y
    J Adv Res; 2022 Mar; 37():221-233. PubMed ID: 35499059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
    Urbanska AM; Zhang X; Prakash S
    Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Close Interplay of Nitro-Oxidative Stress, Advanced Glycation end Products and Inflammation in Inflammatory Bowel Diseases.
    Moura FA; Goulart MOF; Campos SBG; da Paz Martins AS
    Curr Med Chem; 2020; 27(13):2059-2076. PubMed ID: 30182837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
    Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
    Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.